Wen Zhao

Inner Mongolia Yili Industrial Group (China)

Health Outcomes Studied

• Improved Gut Microbiota Composition
• Reduced Flatulence

Papers (5)

• 2025
  Comparative Mechanisms of Different <i>Bifidobacteria</i> in Combating Pathogen Infection and Prolonging the Lifespan in <i>Caenorhabditis elegans</i>.10.3390/microorganisms13122861
• 2024
  <i>Bifidobacterium lactis</i>-Derived Vesicles Attenuate Hippocampal Neuroinflammation by Targeting IL-33 to Regulate FoxO6/P53 Signaling.10.3390/nu16213586
• 2023
  Bifidobacterium animalis subsp. lactis BL-99 ameliorates colitis-related lung injury in mice by modulating short-chain fatty acid production and inflammatory monocytes/macrophages.10.1039/d2fo03374g
• 2022
  <i>In vitro</i> Study of <i>Bifidobacterium lactis</i> BL-99 With Fructooligosaccharide Synbiotics Effected on the Intestinal Microbiota.10.3389/fnut.2022.890316
• 2022
  Bifidobacterium lactis BL-99 protects mice with osteoporosis caused by colitis via gut inflammation and gut microbiota regulation.10.1039/d1fo02218k